logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Myong Cheol Lim

national cancer center - korea (ncc)

42H指数
477论文数
6.6K被引数
收录论文 130
发表时间
logo
Pattern of first recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy晚期上皮性卵巢癌、输卵管癌和腹膜癌经细胞减灭术联合或不联合腹腔热灌注化疗后的首次复发模式
errJournal of Gynecologic Oncology
IF3.7
err2026-05-01
err0
PREAI
errKim, Ji Hyun; Kim, Eun Taeg; Yoo, Heon Jong; Park, Sang-Yoon; Lim, Myong Cheol
err分享
err收藏
Efficacy and toxicity of PARP inhibitor in elderly patients with homologous recombination-deficient newly diagnosed advanced ovarian cancer: the role of dose modification同源重组缺陷的新诊断晚期卵巢癌老年患者中PARP抑制剂的疗效与毒性：剂量调整的作用
errJournal of Gynecologic Oncology
IF3.7
err2026-01-01
err0
errOAAI
errKim, Ji Hyun; Kim, Dongkyu Eugene; Kim, Uisuk; Bae, Jae Kyung; Jin, Wan Hu; Park, Sang-Moon; Lim, Myong Cheol
err分享
err收藏
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancerDurvalumab联合卡铂/紫杉醇和贝伐单抗，然后durvalumab和贝伐单抗联合或不联合奥拉帕尼维持治疗新诊断的非BRCA突变晚期卵巢癌
errAnnals of Oncology
IF65.4
err2025-12-09
err0
PREAI
errP. Harter; F. Trillsch; A. Okamoto; A. Reuss; J.-W. Kim; M.J. Rubio-Pérez; M.A. Vardar; G. Scambia; O. Trédan; G.-B. Nyvang; N. Colombo; M. Bidziński; C. Grimm; S. Lheureux; E. Van Nieuwenhuysen; F. Heitz; R.M. Wenham; S. Nishio; M.C. Lim; G. Marquina
err分享
err收藏
Effect of fascial closure using barbed sutures on incisional hernias in midline laparotomy for gynecological diseases: A multicenter randomized controlled trial (KGOG 4001)使用带倒刺缝线进行筋膜闭合对妇科疾病中线剖腹术切口疝的影响：一项多中心随机对照试验（KGOG 4001）
errPLOS ONE
IF2.6
err2025-11-19
err0
PREAI
errLee, Yong Jae; Kim, Nam Kyeong; Kim, Kidong; Choi, Chel Hun; Lee, Keun Ho; Lee, Jong-Min; Lee, Kwang Beom; Suh, Dong Hoon; Kim, Sunghoon; Kim, Min Kyu; Seong, Seok Ju; Lim, Myong Cheol
err分享
err收藏
Corrigendum to “Oncologic outcomes of minimally invasive surgery vs. abdominal hysterectomy in patients with low-risk, early-stage cervical cancer: A retrospective analysis of KGOG 1028 data based on SHAPE trial eligibility criteria” [Gynecologic Oncology 197 (2025) 91–95].勘误：关于“微创手术与开腹子宫切除术在低风险、早期宫颈癌患者中的肿瘤学结局：基于SHAPE试验纳入标准对KGOG 1028数据的回顾性分析”[妇科肿瘤学 197 (2025) 91–95]。
errGynecologic Oncology
IF3.7
err2025-10-25
err0
PREAI
errJaekyung Bae; Uisuk Kim; E. Sun Paik; Myong Cheol Lim; Moon-Hong Kim; Yun Hwan Kim; Eun Seop Song; Seok Ju Seong; Dong Hoon Suh; Jong-Min Lee; Chulmin Lee; Chel Hun Choi; Sokbom Kang
err分享
err收藏
Influence of Residual Disease on the Efficacy of PARP Inhibitors in Advanced Epithelial Ovarian Cancer: A Systematic Review and Meta Analysis残存病灶对晚期上皮性卵巢癌中PARP抑制剂疗效的影响：一项系统评价和Meta分析
errCancers 2025, Vol. 17, Page 3365
IF0
err2025-10-18
err0
errOAAI
errSekyoung Hwang; Ji Hyun Kim; Uisuk Kim; Hyeong In Ha; Sang-Yoon Park; Myong Cheol Lim
err分享
err收藏
Combined imaging and surgical predictors of cardiophrenic lymph node metastasis in ovarian cancer patients undergoing upfront surgery联合影像学和手术预测因子预测接受 upfront 手术的卵巢癌患者的心膈淋巴结转移
errGynecologic Oncology Reports
IF1.3
err2025-10-01
err0
errOAAI
errKim, Uisuk; Kim, Ji Hyun; Song, Jae Won; Choi, Jin-Ho; Kim, Sun Ho; Park, Sang-Yoon; Lim, Myong Cheol
err分享
err收藏
Landscape of genomic alterations and clinical outcomes in low-grade serous ovarian cancer in Korea韩国低级别浆液性卵巢癌的基因组改变景观及临床结局
errGYNECOLOGIC ONCOLOGY REPORTS
IF0
err2025-09-01
err0
errOAAI
errShim, Yu-Seon; Kim, Ji Hyun; Seo, Sang-soo; Kang, Sokbom; Park, Sang-Yoon; Lim, Myong Cheol
err分享
err收藏
Oncologic outcomes of minimally invasive surgery vs. abdominal hysterectomy in patients with low-risk, early-stage cervical cancer: A retrospective analysis of KGOG 1028 data based on SHAPE trial eligibility criteria低危早期宫颈癌患者中微创手术与腹式子宫切除术的肿瘤学结局：基于SHAPE试验纳入标准对KGOG 1028数据的回顾性分析
errgynecologic oncology
IF4.1
err2025-06-01
err0
PREAI
errBae, Jaekyung; Kim, Uisuk; Paik, E. Sun; Lim, Myong Cheol; Kim, Moon-Hong; Kim, Yun Hwan; Song, Eun Seop; Seong, Seok Ju; Suh, Dong Hoon; Lee, Jong-Min; Lee, Chulmin; Choi, Chel Hun; Kang, Sokbom
err分享
err收藏
Which factors predict the effectiveness of adjuvant treatment in patients with non-high-risk early-stage cervical cancer? Ancillary analysis of KGOG-1028哪些因素预测非高危早期宫颈癌患者辅助治疗的有效性？KGOG-1028的附加分析
errgynecologic oncology
IF4.1
err2025-05-01
err0
PREAI
errKim, Junhwan; Jang, Jieun; Lim, Myong Cheol; Kim, Moon-Hong; Kim, Yun Hwan; Song, Eun Seop; Seong, Seok Ju; Su, Dong Hoon; Lee, Jong-Min; Lee, Chulmin; Choi, Chel Hun
err分享
err收藏
Worldwide barriers of optimal surgical care provision in advanced ovarian cancer全球晚期卵巢癌最佳手术护理提供的障碍
errINTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
IF2.4
err2025-04-25
err0
errOAAI
errShriya Varghese; Myong Cheol Lim; Robert Armbrust; Rene Pareja; Christina Fotopoulou
err分享
err收藏
PALB2 germline pathogenic variants: frequency, clinical features, and functional analysis of c.3350+5G>A variant in 3987 Korean cancer patients
errESMO OPEN
IF8.3
err2025-03-01
err0
PREAI
errKang, M. -c.; Lee, S.; Kim, H.; Kang, H. -s.; Jung, S. -y.; Hwang, J. -a.; Kwon, J.; Lee, K. S.; Lim, M. C.; Park, S. -y.; Sim, S. H.; Choi, W.; Park, J. E.; Cho, E. -h.; Kong, S. -y.
err分享
err收藏
Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis (vol 18, e0294647, 2023)PARP抑制剂维持治疗对新诊断的晚期上皮性卵巢癌的影响：一项Meta分析（卷18，e0294647，2023）
errPLOS ONE
IF2.6
err2025-01-03
err0
errOAAI
errLee, Banghyun; Chang, Suk-Joon; Kwon, Byung Su; Son, Joo-Hyuk; Lim, Myong Cheol; Kim, Yun Hwan; Lee, Shin-Wha; Choi, Chel Hun; Eoh, Kyung Jin; Lee, Jung-Yun; Suh, Dong Hoon; Kim, Yong Beom
err分享
err收藏
A randomized, multicenter, open-label phase III trial of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer: a rationale and study design of the KOV-HIPEC-02 trial一项关于细胞减灭术联合温热腹腔化疗治疗铂耐药复发性卵巢癌的随机、多中心、开放标签III期临床试验：KOV-HIPEC-02试验的合理性与研究设计
errINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
err2025-01-01
err0
PREAI
errKim, Ji Hyun; Park, Eunyoung; Park, Sang-Yoon; Lim, Myong Cheol
err分享
err收藏
CHIPOR, HORSE, and beyond: unraveling the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer
errJOURNAL OF GYNECOLOGIC ONCOLOGY
IF3.7
err2025-01-01
err0
errOAAI
errLim, Myong Cheol
err分享
err收藏
Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines卵巢癌临床实践指南: 韩国妇科肿瘤学会指南的更新
errJOURNAL OF GYNECOLOGIC ONCOLOGY
IF3.7
err2025-01-01
err0
errOAAI
errLee, Banghyun; Chang, Suk-Joon; Kwon, Byung Su; Son, Joo-Hyuk; Lim, Myong Cheol; Kim, Yun Hwan; Lee, Shin-Wha; Choi, Chel Hun; Eoh, Kyung Jin; Lee, Jung-Yun; Lee, Yoo-Young; Suh, Dong Hoon; Kim, Yong Beom
err分享
err收藏
Effects of subcutaneous drain on wound dehiscence and infection in gynecological midline laparotomy: Secondary analysis of a Korean Gynecologic Oncology Group study (KGOG 4001)皮下引流对妇科中线剖腹术中伤口裂开和感染的影响: 韩国妇科肿瘤学组研究 (KGOG 4001) 的二次分析
errEJSO
IF2.9
err2024-09-01
err1
PREAI
errChoi, Chel Hun; Kim, Nam Kyeong; Kim, Kidong; Lee, Yong Jae; Lee, Keun Ho; Lee, Jong-Min; Lee, Kwang Beom; Suh, Dong Hoon; Kim, Sunghoon; Kim, Min Kyu; Seong, Seok Ju; Lim, Myong Cheol
err分享
err收藏
Final analysis of KGOG3046/TRU-D: A phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancerKGOG3046/TRU-D的最终分析：一项关于度伐利尤单抗和特瑞普利单抗联合一线新辅助化疗治疗晚期卵巢癌患者的II期研究
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errPark, J.; Joung, J-G.; Park, E.; Lee, J.; Lim, M. C.; Kim, B-G.; Kim, J-W.; Shin, S.; Kim, S.; Choi, C. H.; Kim, H. S.; Park, S. Y.; Lee, J-Y.
err分享
err收藏
Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage three and four ovarian cancer after interval cytoreductive surgery (FOCUS)KOV-HIPEC-04研究的原理与设计方案：一项针对FOCUS（间歇性肿瘤细胞减灭术后）原发性III期和IV期卵巢癌的III期随机对照试验
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errKim, J.; Kim, J. H.; Park, B.; Bae, J.; Kim, U.; Kim, J-Y.; You, B.; Chang, Y. J.; Park, S-Y.; Lim, M. C.
err分享
err收藏
A first-in-human phase I study of LY4170156, an antibody-drug conjugate targeting folate receptor α (FRα)-expressing advanced solid tumors一项LY4170156（一种靶向叶酸受体α（FRα）表达型晚期实体瘤的抗体制剂偶联物）的首次人体I期研究
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err1
PREAI
errRay-Coquard, I. L.; Liu, J. F.; O'Malley, D.; Oaknin, A.; Pothuri, B.; Lorusso, D.; Eskander, R. N.; Westin, S.; Lakhani, N. J.; McKean, W. B.; Koyama, T.; Kitano, S.; Lim, M. C.; Gomez-Roca, C. A.; Perez Fidalgo, J. A.; Curigliano, G.; Campone, M.; Sharkey, B.; Avsar, E.; Friedman, C.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
S
Soo‐Jin Park
H 指数: 121 · 论文数: 2.4K
G
Giovanni Scambia
H 指数: 117 · 论文数: 3.2K
I
Isabelle Ray‐Coquard
H 指数: 103 · 论文数: 1.1K
M
Michael Friedländer
H 指数: 102 · 论文数: 922
T
Toby Johnson
H 指数: 100 · 论文数: 298
查看更多